mesalamine has been researched along with Low Bone Density in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "There is a high prevalence of low bone mineral density (BMD) among patients with inflammatory bowel disease (IBD) although there is a lack of clinical data on the impact of IBD specific medications and recommended vitamin D (VD) and calcium (Ca) supplements on it." | 1.40 | Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patients. ( Cierny, D; Hlavaty, T; Huorka, M; Killinger, Z; Koller, T; Krajcovicova, A; Letkovsky, J; Miznerova, E; Nevidanska, M; Payer, J; Toth, J; Zelinkova, Z, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krajcovicova, A | 1 |
| Hlavaty, T | 1 |
| Killinger, Z | 1 |
| Miznerova, E | 1 |
| Toth, J | 1 |
| Letkovsky, J | 1 |
| Nevidanska, M | 1 |
| Cierny, D | 1 |
| Koller, T | 1 |
| Zelinkova, Z | 1 |
| Huorka, M | 1 |
| Payer, J | 1 |
| Caprilli, R | 1 |
| Gassull, MA | 1 |
| Escher, JC | 1 |
| Moser, G | 1 |
| Munkholm, P | 1 |
| Forbes, A | 1 |
| Hommes, DW | 1 |
| Lochs, H | 1 |
| Angelucci, E | 1 |
| Cocco, A | 1 |
| Vucelic, B | 1 |
| Hildebrand, H | 1 |
| Kolacek, S | 1 |
| Riis, L | 1 |
| Lukas, M | 1 |
| de Franchis, R | 1 |
| Hamilton, M | 1 |
| Jantschek, G | 1 |
| Michetti, P | 1 |
| O'Morain, C | 1 |
| Anwar, MM | 1 |
| Freitas, JL | 1 |
| Mouzas, IA | 1 |
| Baert, F | 1 |
| Mitchell, R | 1 |
| Hawkey, CJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Synbiotic Treatment in Crohn's Disease Patients[NCT00305409] | 50 participants (Anticipated) | Interventional | 2006-06-30 | Completed | |||
| MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)[NCT04578392] | 181 participants (Anticipated) | Interventional | 2020-07-28 | Recruiting | |||
| A Randomized, Controlled, Open-label Study to Assess the Efficacy of T2 Versus Azathioprine for the Maintenance of Clinical and Endoscopic Remission in Subjects With Crohn's Disease After Surgical Resection[NCT01015391] | 100 participants (Anticipated) | Interventional | 2009-11-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for mesalamine and Low Bone Density
| Article | Year |
|---|---|
Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patients.
Topics: Absorptiometry, Photon; Adalimumab; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; A | 2014 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic; | 2006 |